Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.3895
+0.02266.16%
Volume:1.18M
Turnover:439.17K
Market Cap:26.49M
PE:-0.51
High:0.3900
Open:0.3733
Low:0.3630
Close:0.3669
Loading ...
Feb 01, 2022

Major Issues Report

8-K - Current report
Jan 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jan 26, 2022

Major Issues Report

8-K - Current report
Dec 10, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 15, 2021

Major Issues Report

8-K - Current report
Sep 20, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Jun 16, 2021

Major Issues Report

8-K - Current report
Jun 14, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jun 03, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 03, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 25, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 25, 2021

Correspondence

CORRESP [Cover] - Correspondence
May 19, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2021

Major Issues Report

8-K - Current report
May 10, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933